PDSB
PDS Biotechnology Corp
NASDAQ: PDSB · HEALTHCARE · BIOTECHNOLOGY
$0.97
+1.32% today
Updated 2026-04-30
Market cap
$60.28M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.74
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
PDS Biotechnology Corp (PDSB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-244.20%
ROA
-52.00%
Debt/equity
1.90x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-4.70M | — | — | — |
| 2013 | — | $-6.88M | — | — | — |
| 2014 | — | $-12.20M | — | — | — |
| 2015 | — | $-28.08M | — | — | — |
| 2016 | $0.00 | $-38.82M | — | — | — |
| 2017 | $0.00 | $-50.86M | — | — | — |
| 2018 | $0.00 | $-40.87M | — | — | — |
| 2019 | $0.00 | $-7.00M | — | — | — |
| 2020 | $0.00 | $-14.85M | — | — | — |
| 2021 | $0.00 | $-16.92M | — | — | — |
| 2022 | $0.00 | $-40.85M | — | — | — |
| 2023 | $0.00 | $-42.94M | — | — | — |
| 2024 | $0.00 | $-37.61M | — | — | — |
| 2025 | $0.00 | $-34.50M | — | — | — |